The Dealing and Insider-Trading Code for Research Analysts (2026)
A Research Analyst sits close to information that moves prices, and the rules treat that proximity seriously. You face a blackout window around every recommendation, a ban on trading against your own call, mandatory holding disclosures, and, if you run a firm, a restricted list and controls over what your people trade. This is the dealing code in plain English, and how to keep records that prove you followed it.
Not legal advice. A general explainer for SEBI-registered Research Analysts and research firms. The exact windows, list obligations and any insider-trading code requirements depend on your structure; confirm against the current SEBI regulations and take professional advice.
Why the restrictions exist
The worry the rules are built around is simple: an analyst who can move a stock with a note could buy first, publish second, and sell into the demand they created. Every restriction here, the window, the no-trading-against-your-call rule, the disclosures, the lists, exists to make that impossible, or at least impossible to hide. You do not have to like every line of it to see that being visibly clean on dealing is also good for your reputation, which is the asset your whole practice rests on.
The code, rule by rule
The blackout window
No dealing in the recommended security for 30 days before and 5 days after a recommendation on it. Plan your own trades around your research calendar, not the other way round.
No trading against your own call
You cannot hold a live buy view to clients and sell the same name yourself, in any window. Your book and your published view must not contradict each other.
Holding and conflict disclosure
Every report discloses your position and conflicts. You can own what you cover; you cannot hide that you own it.
Restricted / grey list (firms)
Maintain a list of names that are off-limits or under watch, with controls around who can trade them and when. Mostly a multi-analyst concern.
Employee / associate dealing (firms)
Record, and where appropriate pre-clear, the trades of analysts and associated persons, with periodic holding disclosure, so the firm can prove the code was followed.
Solo analyst versus firm
If you are a solo analyst, most of this collapses into two habits: respect your own trading window around each call, and disclose your holdings in every note. You do not need a restricted-list system; you need a clean record that ties your recommendations to your own trades so the window rule can be shown, not just claimed.
Once you have more than one analyst, it becomes a firm-level control problem: a maintained restricted and grey list, a pre-clearance step for covered trades, and periodic holding disclosures from everyone associated with research. This is the territory the enterprise compliance tools are built for, and for a large firm that machinery is worth it. For most independent RAs it is heavier than the practice needs, and the lighter records-based approach is enough.
The part that actually gets tested: the record
In an inspection or an audit, the question is not โdo you have a trading windowโ but โcan you show you respected itโ. That means being able to line up each recommendation, with its date and time, against the absence of any contrary or in-window trade. The cleaner your recommendation log, the easier this is. When every note you send is timestamped and locked into an audit trail, you have one half of the evidence already, and the dealing record sits naturally alongside it. A research desk like Aktai handles the recommendation side of that record automatically; the dealing log you keep next to it.
FAQ
What is the trading-window restriction for a Research Analyst?
A Research Analyst must not trade in a security around the time of a recommendation on it. The standard window is no dealing in the recommended security for 30 days before and 5 days after the research report or recommendation, and you must never trade contrary to your own live recommendation. The point is to remove the suspicion that you are positioning yourself ahead of your own clients.
Do I have to disclose my own holdings in stocks I write about?
Yes. Every research report has to disclose whether you, or in some cases your associates, hold a position in the security, along with other conflicts of interest. Disclosure is not the same as prohibition: you can hold a stock and write about it, but the client has to be told so they can weigh your view accordingly. Undisclosed holdings are one of the fastest ways to turn a research note into a regulatory problem.
What is a restricted list or grey list?
They are internal controls used mainly by firms with more than one analyst. A restricted list names securities the firm and its people may not trade, usually because of a conflict or material non-public information. A grey list (or watch list) is a quieter internal flag on names under active research, monitored without a full ban. For a solo analyst the concept collapses into your own trading window and holding disclosures; for a firm it becomes a maintained list with controls around it.
How does a research firm track employee or associate trades?
Larger research firms keep records of the trades of their analysts and associated persons, often with a pre-clearance step before a covered trade and periodic disclosure of holdings, so they can show no one dealt against a live call or on the wrong side of the window. A solo analyst does a lighter version: keep your own trade and holding records alongside your recommendation log, so the trading-window rule can be evidenced rather than just asserted.